Literature DB >> 24719490

Faster cognitive decline in elders without dementia and decreased risk of cancer mortality: NEDICES Study.

Julián Benito-León1, Juan Pablo Romero, Elan D Louis, Félix Bermejo-Pareja.   

Abstract

OBJECTIVE: To assess whether faster cognitive decline in elders without dementia is associated with decreased risk of cancer mortality.
METHODS: In this population-based, prospective study of 2,627 people without dementia aged 65 years and older (Neurological Disorders in Central Spain), a 37-item version of the Mini-Mental State Examination (37-MMSE) was administered at 2 visits (baseline and follow-up, approximately 3 years later). We divided change in 37-MMSE into tertiles (lower tertile ≥ 2 point improvement in score, higher tertile ≥ 2 point decline in score). Community-dwelling elders were followed for a median of 12.9 years, after which the death certificates of those who died were examined.
RESULTS: A total of 1,003 (38.2%) died, including 339 (33.8%) deaths among participants who were in the higher tertile of 37-MMSE change and 664 (66.2%) deaths among those in the remaining tertiles. Cancer was reported significantly less often in those in the higher tertile of MMSE change (20.6%) than in those in the remaining tertiles (28.6%): in an unadjusted Cox model, hazard ratio for cancer mortality in participants within the higher tertile = 0.75 (p = 0.04) compared with the participants within the remaining tertiles. In a Cox model that adjusted for a variety of demographic factors and comorbidities, hazard ratio for cancer mortality in participants within the higher tertile = 0.70 (p = 0.01).
CONCLUSION: In this population-based, prospective study of community-dwelling elders without dementia, faster cognitive decline was associated with a decreased risk of cancer mortality. Further studies are required to elucidate this inverse association in elders without dementia.

Entities:  

Mesh:

Year:  2014        PMID: 24719490      PMCID: PMC4001199          DOI: 10.1212/WNL.0000000000000350

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Inflammation and Alzheimer's disease.

Authors:  R W Jones
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

Review 2.  Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders?

Authors:  Frederick Harris; Sarah R Dennison; David A Phoenix
Journal:  FASEB J       Date:  2012-02-03       Impact factor: 5.191

3.  Effects of age and β-amyloid on cognitive changes in normal elderly people.

Authors:  Hwamee Oh; Cindee Madison; Thaddeus J Haight; Candace Markley; William J Jagust
Journal:  Neurobiol Aging       Date:  2012-03-17       Impact factor: 4.673

4.  Alzheimer's disease is associated with decreased risk of cancer-specific mortality: a prospective study (NEDICES).

Authors:  Juan Pablo Romero; Julián Benito-León; Elan D Louis; Félix Bermejo-Pareja
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Cerebrovascular disease incidence in central Spain (NEDICES): a population-based prospective study.

Authors:  Antonio Martínez-Salio; Julián Benito-León; Jaime Díaz-Guzmán; Félix Bermejo-Pareja
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

6.  Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.

Authors:  Alberto Villarejo; Julián Benito-León; Rocío Trincado; Ignacio J Posada; Verónica Puertas-Martín; Raquel Boix; M Rm A José Medrano; Félix Bermejo-Pareja
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES).

Authors:  Julián Benito-León; Elan D Louis; Félix Bermejo-Pareja
Journal:  J Psychiatr Res       Date:  2013-09-20       Impact factor: 4.791

8.  Rate of cognitive decline during the premotor phase of essential tremor: a prospective study.

Authors:  Julián Benito-León; Elan D Louis; Álvaro Sánchez-Ferro; Félix Bermejo-Pareja
Journal:  Neurology       Date:  2013-05-22       Impact factor: 9.910

9.  Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study.

Authors:  Jane A Driver; Alexa Beiser; Rhoda Au; Bernard E Kreger; Greta Lee Splansky; Tobias Kurth; Douglas P Kiel; Kun Ping Lu; Sudha Seshadri; Phillip A Wolf
Journal:  BMJ       Date:  2012-03-12

10.  Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.

Authors:  Ole Audun Werner Haabeth; Kristina Berg Lorvik; Clara Hammarström; Ian M Donaldson; Guttorm Haraldsen; Bjarne Bogen; Alexandre Corthay
Journal:  Nat Commun       Date:  2011       Impact factor: 14.919

View more
  14 in total

Review 1.  Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review.

Authors:  Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota
Journal:  Mech Ageing Dev       Date:  2017-05-11       Impact factor: 5.432

Review 2.  Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.

Authors:  Cristina Lanni; Mirco Masi; Marco Racchi; Stefano Govoni
Journal:  Mol Psychiatry       Date:  2020-05-07       Impact factor: 15.992

Review 3.  The role of cerebrovascular disease when there is concomitant Alzheimer disease.

Authors:  Prashanthi Vemuri; David S Knopman
Journal:  Biochim Biophys Acta       Date:  2015-09-25

4.  Increased Odds of Melanoma: Parkinson's Disease, Essential Tremor, Dystonia versus Controls.

Authors:  Sherif Y Shalaby; Elan D Louis
Journal:  Neuroepidemiology       Date:  2016-01-28       Impact factor: 3.282

5.  Relationship of Cancer to Brain Aging Markers of Alzheimer's Disease: The Framingham Heart Study.

Authors:  Apar Gupta; Sarah R Preis; Alexa S Beiser; Greta L Splansky; Charles S DeCarli; Rhoda Au; Jane A Driver
Journal:  Adv Geriatr Med Res       Date:  2019-07-04

6.  Inverse correlation between Alzheimer's disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?

Authors:  Jian-Ming Li; Chao Liu; Xia Hu; Yan Cai; Chao Ma; Xue-Gang Luo; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2014-11-14       Impact factor: 2.474

7.  Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.

Authors:  Peter Hobson; Jolyon Meara
Journal:  BMJ Open       Date:  2018-02-14       Impact factor: 2.692

8.  Education and risk of incident dementia during the premotor and motor phases of essential tremor (NEDICES).

Authors:  Julián Benito-León; Israel Contador; Elan D Louis; Stephanie Cosentino; Félix Bermejo-Pareja
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Adrenal Pheochromocytoma Incidentally Discovered in a Patient With Parkinsonism.

Authors:  Luigi Petramala; Antonio Concistrè; Cristiano Marinelli; Laura Zinnamosca; Gino Iannucci; Piernatale Lucia; Giuseppe De Vincentis; Claudio Letizia
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

10.  Symptomatic Atherosclerotic Disease and Decreased Risk of Cancer-Specific Mortality: A Prospective, Population-Based Study (NEDICES).

Authors:  Julián Benito-León; Jesús González de la Aleja; Antonio Martínez-Salio; Elan D Louis; Judith H Lichtman; Félix Bermejo-Pareja
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.